These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27159394)

  • 1. Cre-inducible human CD59 mediates rapid cell ablation after intermedilysin administration.
    Feng D; Dai S; Liu F; Ohtake Y; Zhou Z; Wang H; Zhang Y; Kearns A; Peng X; Zhu F; Hayat U; Li M; He Y; Xu M; Zhao C; Cheng M; Zhang L; Wang H; Yang X; Ju C; Bryda EC; Gordon J; Khalili K; Hu W; Li S; Qin X; Gao B
    J Clin Invest; 2016 Jun; 126(6):2321-33. PubMed ID: 27159394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid conditional targeted ablation of cells expressing human CD59 in transgenic mice by intermedilysin.
    Hu W; Ferris SP; Tweten RK; Wu G; Radaeva S; Gao B; Bronson RT; Halperin JA; Qin X
    Nat Med; 2008 Jan; 14(1):98-103. PubMed ID: 18157141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.
    Wickham SE; Hotze EM; Farrand AJ; Polekhina G; Nero TL; Tomlinson S; Parker MW; Tweten RK
    J Biol Chem; 2011 Jun; 286(23):20952-62. PubMed ID: 21507937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid conditional targeted ablation model for hemolytic anemia in the rat.
    Hanson MM; Liu F; Dai S; Kearns A; Qin X; Bryda EC
    Physiol Genomics; 2016 Aug; 48(8):626-32. PubMed ID: 27368711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59.
    Johnson S; Brooks NJ; Smith RA; Lea SM; Bubeck D
    Cell Rep; 2013 May; 3(5):1369-77. PubMed ID: 23665225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.
    Hughes TR; Ross KS; Cowan GJ; Sivasankar B; Harris CL; Mitchell TJ; Morgan BP
    Mol Immunol; 2009 Apr; 46(7):1561-7. PubMed ID: 19200600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.
    LaChapelle S; Tweten RK; Hotze EM
    J Biol Chem; 2009 May; 284(19):12719-26. PubMed ID: 19293153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disentangling the roles of cholesterol and CD59 in intermedilysin pore formation.
    Boyd CM; Parsons ES; Smith RA; Seddon JM; Ces O; Bubeck D
    Sci Rep; 2016 Dec; 6():38446. PubMed ID: 27910935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of ILY, VLY and Sm-hPAF interaction with human CD59.
    Kawaguchi Y; Tabata A; Nagamune H; Ohkura K
    Anticancer Res; 2013 Jul; 33(7):2901-4. PubMed ID: 23780977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytolytic activity of vaginolysin strictly depends on cholesterol and is potentiated by human CD59.
    Zilnyte M; Venclovas Č; Zvirbliene A; Pleckaityte M
    Toxins (Basel); 2015 Jan; 7(1):110-28. PubMed ID: 25590277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin.
    Giddings KS; Zhao J; Sims PJ; Tweten RK
    Nat Struct Mol Biol; 2004 Dec; 11(12):1173-8. PubMed ID: 15543155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermedilysin cytolytic activity depends on heparan sulfates and membrane composition.
    Drabavicius G; Daelemans D
    PLoS Genet; 2021 Feb; 17(2):e1009387. PubMed ID: 33577603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model.
    Hu W; Jin R; Zhang J; You T; Peng Z; Ge X; Bronson RT; Halperin JA; Loscalzo J; Qin X
    Blood; 2010 Sep; 116(9):1613-22. PubMed ID: 20511540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of catabolite control protein A in the regulation of intermedilysin production by Streptococcus intermedius.
    Tomoyasu T; Tabata A; Hiroshima R; Imaki H; Masuda S; Whiley RA; Aduse-Opoku J; Kikuchi K; Hiramatsu K; Nagamune H
    Infect Immun; 2010 Sep; 78(9):4012-21. PubMed ID: 20624907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of complement inhibitory protein CD59 contributes to humoral autoimmunity against astrocytes.
    Wang Z; Guo W; Liu Y; Gong Y; Ding X; Shi K; Thome R; Zhang GX; Shi FD; Yan Y
    Brain Behav Immun; 2017 Oct; 65():173-182. PubMed ID: 28476558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid screening method for detecting highly pathogenic Streptococcus intermedius strains carrying a mutation in the lacR gene.
    Tomoyasu T; Matoba M; Takao A; Tabata A; Whiley RA; Maeda N; Nagamune H
    FEMS Microbiol Lett; 2018 Feb; 365(3):. PubMed ID: 29228148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocyte Death Preferentially Induces Liver Injury and Inflammation Through the Activation of Chemokine (C-C Motif) Receptor 2-Positive Macrophages and Lipolysis.
    Kim SJ; Feng D; Guillot A; Dai S; Liu F; Hwang S; Parker R; Seo W; He Y; Godlewski G; Jeong WI; Lin Y; Qin X; Kunos G; Gao B
    Hepatology; 2019 May; 69(5):1965-1982. PubMed ID: 30681731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive- and Negative-Control Pathways by Blood Components for Intermedilysin Production in Streptococcus intermedius.
    Tomoyasu T; Yamasaki T; Chiba S; Kusaka S; Tabata A; Whiley RA; Nagamune H
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28607101
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effects of different combinations of human MCP, DAF, and CD59 on complement-dependent cytolysis in NIH 3T3 cells.
    Yang X; Deng J; Jiang Z; Liao DJ; Jiang H
    Exp Clin Transplant; 2012 Feb; 10(1):49-54. PubMed ID: 22309420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinctive histidine residue is essential for in vivo glycation-inactivation of human CD59 transgenically expressed in mice erythrocytes: Implications for human diabetes complications.
    Sahoo R; Ghosh P; Chorev M; Halperin JA
    Am J Hematol; 2017 Nov; 92(11):1198-1203. PubMed ID: 28815695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.